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Conclusions: We found significant correlations of IVUS-VH determined atherosclerotic
plaque components between coronary and carotid arteries in patients with atherosclerosis
involving both arterial beds.
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Background: The frequency, type and extent of neoatherosclerosis within drug-eluting
stents (DES) has not been described during very long-term follow-up. Moreover, it is
unknown whether DES eluting sirolimus differ from those eluting paclitaxel in the
propensity for neoatherosclerosis during long-term follow-up.
Methods: The SIRTAX LATE OCT population was analyzed for evidence of neoath-
erosclerosis within stented segments five years after DES implantation. Using OCT
definitions according to the Consensus Statement of the International Working Group of
OCT, we assessed the presence of fibrocalcific plaques, fibroatheromas, macrophage
accumulations, microvessels, as well as surface erosions and ruptures in each single
frame. Plaques were considered to be present in case of a longitudinal extension of at least
1mm, and all other findings had to be visualized in at least three consecutive frames.
Results: All segments were independently assessed by two experienced observers. A
total of 89 event-free patients with 41 lesions treated with SES (41 patients) and 48 lesions
treated with PES (48 patients) were analysed at five years of follow-up. Neoatheroscle-
rotic plaques were observed in 15% of lesions, and fibroatheromas (12.4%) were more
common than fibrocalcific plaques (5.6%). While macrophage accumulations were
frequently present (32.6%), microvessels (2.2%) and surface erosions (2.2%) were rare,
and no plaque rupture was observed. Neoatherosclerotic plaques were more common
among lesions treated with PES (25%) than SES (5%; P 0.01), and differences between
stent types applied to both the frequency of fibrocalcific plaques (SES 0%, PES 10.5%,
p0.041) as well as fibroatheromas (SES 4.9% vs. PES 18.8%, p0.046). Similarly,
macrophage accumulations were more frequent among lesions treated with PES (47.9%)
than SES (14.6%, p0.001).
Conclusions: Among event-free patients, neoatherosclerotic plaques were observed in
15% of lesions five years after DES implantation. The frequency, type and extent of
neoatherosclerotic changes were importantly influenced by the implanted DES type.
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Background: Cavity aperture resulting from plaque rupture is often located in the
proximal for STEMI patients and distal for NSTEMI patients. To investigate the
characteristics of lesions avoiding onset of AMI through observing lesion cavities in
angina pectoris patients.
Methods: Target population consisted of 232 patients (250 lesions) with ischemic heart
disease (excluding AMI patients) undergoing OCT prior to therapeutic treatment that
presented to our facility from May, 2009 to December, 2011. Of these, OCT findings
determined a cavity at stenosed location in 22 patients. A comparative investigation was
performed on cavity aperture location: proximal side (Group P: 12 lesions); others (group
D: 8 lesions).
Results: OCT findings Distal lumen area (group P: 5.971.88, group D: 8.682.51,
p0.05), minimal lumen area (1.951.21, 2.681.31), cavity area (1.871.28,
3.091.02, p0.05), proximal lumen area (6.762.24, 10.723.74, p0.05) Location of
plaque rupture site was: proximal (group P: 66%, group D: 38%); middle (25%, 12%);
distal (9%, 50%, p0.05). There was no difference determined between groups for
location of MLA or residual low intensity area. Furthermore, there was a higher tendency
for group D to have spotty calcification at lesion location compared to Group P (50%,
88%, respectively).
Conclusions: In comparison to those patients with proximal cavity aperture, distal cavity
aperture patients had larger vessel diameter, larger plaque volume and plaque disruption
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Background: Diabetes mellitus (DM) is a well-established risk factor for coronary artery
disease (CAD). However, little is known about relationship the prevalence of DM and
coronary plaque vulnerability assessed by integrated backscatter intravascular ultrasound
(IB-IVUS).
Methods: One hundred sixteen consecutive patients with stable CAD who underwent
percutaneous coronary intervention were enrolled. Nonculprit coronary lesions with mild
to moderate stenosis were measured by IB-IVUS. A total of 20 IB-IVUS images were
recorded at an interval of 0.5 mm for 10 mm length in each plaque. Patients were divided
into two groups: the DM group and the non-DM group. We assessed the relations among
DM and coronary plaque instability using IB-IVUS.
Results: Plaque volume (PV) and percentage of PV (%PV, 100PV/Vessel Volume) in
the DM group were significantly higher than those in the non-DM group (66.022.7 mm3
vs. 56.821.2 mm3, P0.0278 and 42.59.7% vs. 39.08.8%, P0.0453, respectively).
Lipid volume (LV) and percentage of LV (%LV, 100LV/PV) in the DM group were
significantly higher than those in the non-DM group (28.915.5 mm3 vs. 22.213.0
mm3, P0.0130 and 42.112.4% vs. 37.312.2%, P0.0409, respectively). Further-
more, multiple regression analysis revealed that the prevalence of DM was independently
associated with PV (p0.0351), LV (p0.0164) and %LV (p0.0304) among IVUS
parameters in addition to other metabolic factors.
Conclusions: Nonculprit coronary lesions in patients with DM are associated with more
lipid-rich plaque content and a greater PV, suggesting that DM patients increased plaque
vulnerability.
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Background: Despite the technical advantage of improved image resolutions, higher-
frequency IVUS imaging may theoretically be susceptible to impaired lumen and vessel
border detection due to higher blood scattering and lower signal penetration within the
tissue. This first-in-human study aimed to evaluate the feasibility of 60MHz IVUS
imaging with a novel multi-frequency IVUS system in in-vivo quantitative assessment of
native coronary lesions.
Methods: A total of 121 matched cross-sections were imaged and compared at 40MHz
and 60MHz. Visibilities of lumen and vessel borders were classified into 3 grades (good:
entire circumference visible, fair: 75% visible, and poor: 75% visible). Quantitative
evaluation included area and minimum diameter measurements of lumen (LA; MLD) and
vessel (VA; MVD).
Results: Good visualization of lumen border was achieved in 87.6% with 60MHz
compared to 79.3% with 40MHz (p0.08), while the rates of good vessel border
detection were similar between the 2 frequency imagings (p0.79). Overall, the 40MHz
and 60MHz imagings showed comparable visibilities of lumen and vessel borders. All
quantitative measurements significantly correlated with good agreements (LA: r20.97;
MLD: r20.95; VA: r20.97; MVD: r20.93, p0.001 for all) between the 2 frequency
imagings.
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Conclusions: In this first-in-human feasibility study, the theoretical concerns of higher-
frequency IVUS were not documented in clinical settings, demonstrating a comparable
ability of 60MHz imaging in measurements of diseased coronary arteries as compared
with conventional 40MHz imaging.
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Background: The vascular tissue reaction to acute incomplete stent apposition (ISA) is
scarcely known. The aim of this study is characterizing the vascular response to acute ISA
in vivo and looking for predictors of incomplete healing.
Methods: Optical coherence tomography studies from 3 randomized trials including
different types of stents were sequentially analysed after implantation and at 6-13 months.
Segments with acute ISA were matched with the follow-up study using fiduciary
landmarks. The pattern of healing was categorized according to morphologic criteria.
Volumetric and per strut analysis (apposition and coverage) were performed. Predictors
for ISA correction and for completeness of coverage were sought.
Results: 66 stents (43 patients) were sequentially analyzed. 78 ISA segments were
identified. ISA volume decreased and 71.5% of the ISA segments were spontaneously
corrected at follow-up. Coverage of acute ISA segments is delayed with respect to
well-apposed segments (RR 2.37; 95% CI 2.01 – 2.78). ISA coverage depended on the
type of stent, but acute ISA volume was the only independent predictor for persistent ISA
(OR 3.19, 95% CI 1.43 – 7.12) and for massively delayed coverage (OR 1.37, 95% CI
1.09 – 1.74). Acute ISA size (estimated as ISA volume or maximal ISA distance per strut)
was an independent predictor of ISA persistence and of delayed healing at follow-up.
Maximal ISA distances 270 m post stent implantation appeared grossly covered and
spontaneously re-apposed in 100% of cases at follow-up; whilst maximal ISA distances
850 m) resulted in persisting ISA and grossly delayed coverage in 100% of cases.
Conclusions: The neointimal healing tends to reduce ISA, often integrating it completely
into the vessel wall and resulting in characteristic morphologic patterns. Coverage of ISA
segments is delayed with respect to well-apposed segments. The larger the size of acute
ISA, the larger the likelihood of persisting malapposed at follow-up and of delayed
healing.
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Background: Intravascular NIRS is well-validated for coronary lipid core plaque (LCP)
detection. Initial work has shown ability to differentiate LCP cap thickness by relative
cholesterol/collagen contribution to overall signal. This study assessed NIRS vs histology
LCP cap thickness in coronary autopsy specimens using improved multivariate methods,
reproducibility, and clinical applicability.
Methods: NIRS was performed through blood in 212 coronary segments from 84
autopsy hearts. Histologic sections were analyzed every 2mm, and fibrous cap thickness
in each LCP section was measured. Accuracy of classifying fibrous caps as thin
(65m), intermediate, or thick (400m) was tested for a combined-model approach
using cross-validation.
Results: Thin regions were present in 70/901 (7.8%) sections and thick regions were
present in 120/901 (13.3%) sections. The algorithm classified thin and thick fibrous cap
regions with an AUC of 0.78 (95% CI:0.72-0.85). Very good reproducibility for separate
catheter acquisitions was demonstrated: correlation coefficients of 0.96 for thin regions
and 0.92 for thick regions. A retrospective analysis of fibrous cap thickness conducted in
clinical NIRS scans containing LCPs, shows applicability of the technique to in vivo
images.
Conclusions: This novel catheter-based NIRS system already in clinical use to identify
LCPs in patients, accurately and reproducibly classified fibrous caps overlying LCP
through blood in coronary autopsy specimens. Assessment of fibrous cap thickness may
be of value in management of patients with coronary artery disease and development of
anti-athero drugs.
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Background: After the first-in-man REMEDEE Study report, the dual therapy COMBO
Stent (OrbusNeich Medical, FL, USA) was further evaluated for its in-vivo pro-healing
benefit and neointimal suppression as a DES in this Study.
Methods: In this prospective, single center study, 61 patients treated by COMBO Stent
(9 months DAPT) were randomly assigned to 4 monthly groups (2nd to 5th month,
1:2:2:1 ratio). OCT was performed sequentially 3 times at baseline PCI, early follow-up
in 4 monthly groups (for early stent coverage using 6 stringent Categories; every frame &
strut analyzed), and then 9 months (for OCT neointima analysis; every 5 frames). Clinical
event adjudication, core lab. QCA & OCT analyses were undertaken by Cardiovascular
Research Foundation, NY.
Results: 61 patients (32% DM) received 88 COMBO stents. From 2nd to 5th monthly
group, covered struts % increased significantly from 77.2%, 82.2%, 91.5% to 98.1%
(100% coverage at 150 days; refer to Figure). At 9 months, mean OCT neointimal
thickness was 0.135mm and area 1.259 mm2, with a corresponding QCA late loss of
0.31mm. At 9-month FU, 1 patient had non-ischemic angiographic stenosis treated by
simple ballooning; otherwise no other MACE (restenosis nor stent thrombosis) was
recorded to date, totaling a MACE rate of only 1.64% (1/61) throughout a mean FU period
of 508 days. Final core lab. results are pending.
Conclusions: The COMBO stent is the first DES with a healing profile established (rapid
strut coverage). The promising outcomes after almost 18 months FU appeared to support
the benefits of the dual therapy approach.
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